leisure time -WSS

leisure time

author：leisure time 2025-09-27 16:57:04 - browse：675

A screen at the New York Stock Exchange last November. Michael M. Santiago/Getty Images

Pfizer spent more than four hours Thursday laying out its oncology program to investors. But the company also spent some time talking about the effects of the Inflation Reduction Act on its pipeline.

The drug giant, which is facing investor dissatisfaction after a year in which its stock dropped 44%, said it would be focusing on drugs that are based on proteins, not small molecule pills as it has traditionally developed. (Pfizer’s current best-seller in oncology, Ibrance for breast cancer, is a small molecule pill.) It said the mix of small molecule drugs in its cancer portfolio will drop from 94% last year to 35% in 2030.

That matters because small molecules are more vulnerable to generic competition and the Medicare price negotiation introduced by the IRA. Suneet Varma, the commercial president of Pfizer’s oncology unit, said “this planned shift to biologics is expected to support the accelerated growth in both the top and bottom line,” referring to the revenue and profit lines of a balance sheet.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Heart attack and stroke risk calculators need revising
Next article： House passes resolution saying Israel isn't a 'racist or apartheid state'

focus

entertainment

WSS

Biden tests positive for Covid

In early work, researchers turn to CRISPR to treat Alzheimer's

Manchin plays down potential 3rd

Biden administration sends mixed signals on US soldier who crossed into North Korea

Medicare has a new plan to address drug shortages

Ford plant in Missouri shuts down over 'possible threat,' sheriff's office says

hotspot

leisure time

hotspot

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Vivek Ramaswamy, who's embraced Trump on the campaign trail, condemned him after Jan. 6

As demand for Covid shots wanes, Moderna seeks its next success

Ford plant in Missouri shuts down over 'possible threat,' sheriff's office says

Heart attack and stroke risk calculators need revising

Google and Epic fight stronger regulation of AI in health care

Walensky prepares to leave CDC — and Congress — behind

US soldier in North Korean custody after crossing DMZ line

Apple is now the first public company to be valued at $3 trillion

Sanofi seeks simpler, safer CRISPR sickle cell cure

explore

ARCH Venture Partners tops STAT's 2023 biotech VC rankings

Medicare has a new plan to address drug shortages

Idaho college killings: Prosecutors dispute DNA could have been planted at murder scene

Idaho college killings: Prosecutors dispute DNA could have been planted at murder scene

Flagship, Pfizer team up in deal worth up to $7 billion

Medicare to cover more brain scans for Alzheimer’s patients

hotspot

focus

entertainment

Wikipedia